The Beaujon Hospital is located in Clichy, Paris, France and is operated by APHDP. It was named after Nicolas Beaujon, an eighteenth-century French banker. It opened in 1935 and was designed by Jean Walter.

There are 464 beds in Service d'Hépatogastroentérologie - Hôpital Beaujon.

During the past decade, Service d'Hépatogastroentérologie - Hôpital Beaujon conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Service d'Hépatogastroentérologie - Hôpital Beaujon" #1 collaborator was "Ministry of Health, France" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Rennes University Hospital" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Service d'Hépatogastroentérologie - Hôpital Beaujon" are "Evidence of Liver Transplantation" (2 trials), "Hepatitis B, Chronic" (2 trials), "Chronic Hepatitis C" (1 trials), "Hepatitis C" (1 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "Service d'Hépatogastroentérologie - Hôpital Beaujon" in a lesser frequency.

Most popular intervention types in "Service d'Hépatogastroentérologie - Hôpital Beaujon" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ribavirin" (2 trials), "Mycophenolate mofetil" (1 trials), "Peg-IFN alfa-2a" (1 trials), "Peginterferon alfa-2b" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service d'Hépatogastroentérologie - Hôpital Beaujon" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Service d'Hépatogastroentérologie - Hôpital Beaujon". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Service d'Hépatogastroentérologie - Hôpital Beaujon, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Service d'Hépatogastroentérologie - Hôpital Beaujon, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".